Lexacalcitol
Alternative Names: KH 1060Latest Information Update: 25 Jul 2001
At a glance
- Originator LEO Pharma
- Developer LEO Pharma; Nonindustrial source; Roche
- Class Anti-inflammatories; Antihyperglycaemics; Antipruritics; Antipsoriatics; Vitamin D analogues
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer; Pancreas transplant rejection; Psoriasis; Renal transplant rejection; Skin disorders; Type 1 diabetes mellitus
Most Recent Events
- 25 Jul 2001 Discontinued-Preclinical for Cancer in Canada (Unknown route)
- 25 Jul 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 15 Nov 2000 Discontinued-Preclinical for Pancreas transplant rejection in Belgium (Unknown route)